Pharmafile Logo

dual tasking

- PMLiVE

‘Funny’, ha ha: how neurodiverse comedy can help us understand each other

Ever since Hans Asperger showed cartoons to his ‘little professors’ and they didn’t laugh, it was believed that people with autism lacked a sense of humour. Today, a new wave...

11 London

- PMLiVE

BMS and Eisai to collaborate in deal worth up to $3.1bn

The two companies will work on developing a drug for endometrial, ovarian, lung and breast cancers

Staying in the loop – six principles for impactful integrated communications

In a digitalised world, accelerated by the COVID-19 pandemic, pharmaceutical companies must work smarter to engage busy external stakeholders with endless content at their fingertipsIn this month’s edition of PME James...

Lucid Group Communications Limited

- PMLiVE

Kite partners with Shoreline Biosciences to develop allogeneic cell therapies

The deal could be worth a total of up to $2.3bn, with Shoreline receiving an undisclosed upfront payment

- PMLiVE

Fishawack Health acquires digital marketing agency closerlook

closerlook leverages AI and data analytics to develop omnichannel strategies, creative and digital media solutions for life sciences brands

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Impetus Digital

Using Technology to Improve Patient Experience

Dyan Bryson from Inspired Health Strategies discusses Patient Focused Drug Development, best practices for designing diverse and patient-centric trials, and how to use technology to improve the patient experience. She...

Impetus Digital

- PMLiVE

Evoke KYNE promotes Carolyn Coyle to executive vice president

Previously, Coyle also worked as senior vice president in the healthcare practice at Ruder Finn

- PMLiVE

McCann Health New York promotes Matt Silver to the new role of president

Silver first joined McCann Health New York in 2017 as executive vice president and managing director

- PMLiVE

PureTech adds potential IBD therapeutic to pipeline after buying out Alivio Therapeutics

Alivio is developing therapeutic candidates for a number of inflammatory disorders

Biogen Idec building

Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease

The drug failed to meet the primary efficacy endpoint in a phase 2 study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links